An evaluation of the impact of aggressive hypertension, diabetes and smoking cessation management on CVD outcomes at the population level: a dynamic simulation analysis

John Pastor Ansah, Ryan Leung Hoe Inn, Salman Ahmad, John Pastor Ansah, Ryan Leung Hoe Inn, Salman Ahmad

Abstract

Background: Evidence from randomized control trials suggest that coupled with smoking cessation interventions, CVD events can be reduced significantly if hypertension and diabetes patients are properly managed, raising practical what-if questions at the population level. This research aims to develop a dynamic simulation model using the systems modelling methodology of system dynamics, to evaluate the medium to long-term impact of hypertension and diabetes management, as well as smoking cessation intervention on CVD events, CVD deaths and post-CVD population.

Methods: The systems modelling methodology of system dynamics was used to develop a simulation model to evaluate the impact of aggressive hypertension, diabetes and smoking cessation management on CVD outcomes at the population level.

Result: The insights from this research suggest that despite that at the individual level, hypertension management is associated with the highest risk reduction for CVD (50%) compared to diabetes and smoking (20%) and is also the most prevalent risk factor, at the population level, diabetes management interventions are projected to have higher impact on reducing CVD events compared to hypertension management or smoking cessation interventions. However, a combined intervention of diabetes and hypertension management, as well as smoking cessation has the most impact on CVD outcomes.

Conclusion: Due to aging population and the increasing prevalence of chronic conditions in Singapore, the number of CVD events in Singapore is projected to rise significantly in the near future-hence the need for proactive planning to implement needed interventions. Findings from this research suggest that CVD events and its associated deaths and disabilities could be reduced significantly if diabetes and hypertension patients are aggressively managed.

Keywords: CVD; Chronic disease management; Singapore; System dynamics.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Risk factors sub-model (diabetes, and hypertension)
Fig. 2
Fig. 2
Smoking sub-model
Fig. 3
Fig. 3
Cerebrovascular disease sub-model

References

    1. World Health Organization. GLOBAL STATUS REPORT on noncommunicable diseases 2014 [Internet]. 2014. Available from: . Accessed Jan 2019.
    1. Yusuf Salim, Reddy Srinath, Ôunpuu Stephanie, Anand Sonia. Global Burden of Cardiovascular Diseases. Circulation. 2001;104(22):2746–2753. doi: 10.1161/hc4601.099487.
    1. Kahn R, Robertson RM, Smith R, Eddy D. The Impact of Prevention on Reducing the Burden of Cardiovascular Disease. Circulation. 2008;118(5):576–585. doi: 10.1161/CIRCULATIONAHA.108.190186.
    1. Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132(17):1667–1678. doi: 10.1161/CIRCULATIONAHA.114.008720.
    1. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.
    1. Tan WS, Heng BH, Chua KS-G, Chan KF. Factors predicting inpatient rehabilitation length of stay of acute stroke patients in Singapore. Arch Phys Med Rehabil. 2009;90(7):1202–1207. doi: 10.1016/j.apmr.2009.01.027.
    1. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–967. doi: 10.1016/S0140-6736(15)01225-8.
    1. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387(10017):435–443. doi: 10.1016/S0140-6736(15)00805-3.
    1. HOPE Effects of an angiotensin-converting–enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145–153. doi: 10.1056/NEJM200001203420301.
    1. ADVANCE Collaborative Group. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New Engl J Med. 2008;358(24):2560–2572. doi: 10.1056/NEJMoa0802987.
    1. Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–2559. doi: 10.1056/NEJMoa0802743.
    1. Malhotra R, Chan A, Malhotra C, Østbye T. Prevalence, awareness, treatment and control of hypertension in the elderly population of Singapore. Hypertens Res. 2010;33(12):1223–1231. doi: 10.1038/hr.2010.177.
    1. Rhen W, Lee W. The changing demography of diabetes mellitus in Singapore. Diabetes Res Clin Pract. 2000;50(SUPPL. 2):35–39.
    1. Ministry of Health Singapore . Encyclopedia of Epidemiology [Internet] Thousand Oaks: SAGE Publications, Inc.; 2010. National Health Care Survey; pp. 52–57.
    1. National Center for Health Statistics (US). Health, United States, 2017: With Special Feature on Mortality [Internet]. Hyattsville: National Center for Health Statistics (US); 2018. Available from: .
    1. Statistics Canada. Canadian Community Health Survey. Table 13-10-0096-09 High blood pressure by age group. Ontario: Statistics Canada; 2018.
    1. Satoh A, Arima H, Ohkubo T, Nishi N, Okuda N, Ae R, Inoue M, Kurita S, Murakami K, Kadota A, Fujiyoshi A, Sakata K, Okamura T, Ueshima H, Okayama A, Miura K. Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA 2010. J Hypertens. 2017;35(2):401–408. doi: 10.1097/HJH.0000000000001169.
    1. Korean Society Hypertension (KSH); Hypertension Epidemiology Research Working Group. Kim HC, Cho MC. Korea hypertension fact sheet 2018. Clin Hypertens. 2018;24:13. doi: 10.1186/s40885-018-0098-0.
    1. Statistics Canada. Health Facts: Diabetes 2016. 2017. . Accessed Jan 2019.
    1. Goto A, Noda M, Inoue M, Goto M, Charvat H. Increasing number of people with diabetes in Japan: is this trend real? Intern Med. 2016;55(14):1827–1830. doi: 10.2169/internalmedicine.55.6475.
    1. Won JC, Lee JH, Kim JH, Kang ES, Won KC, Kim DJ, Lee MK. Diabetes fact sheet in Korea, 2016: an appraisal of current status. Diabetes Metab J. 2018;42(5):415–424. doi: 10.4093/dmj.2018.0017.
    1. World Health Organization. WHO global report on trends in prevalence of tobacco smoking 2000–2025. second edition. 2018. . Accessed Jan 2019.
    1. Homer JB, Hirsch GB. System dynamics modeling for public health : background and opportunities. Am J Public Health. 2006;96(3):452–458. doi: 10.2105/AJPH.2005.062059.
    1. Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, et al. Future cardiovascular disease in China Markov model and risk factor scenario projections from the coronary heart disease policy model-China. Circ Cardiovasc Qual Outcomes. 2010;3(3):243–252. doi: 10.1161/CIRCOUTCOMES.109.910711.
    1. Konfino J, Ferrante D, Mejia R, Coxson P, Moran A, Goldman L, et al. Impact on cardiovascular disease events of the implementation of Argentina’s national tobacco control law. Tob Control. 2014;23(2):1–8. doi: 10.1136/tobaccocontrol-2012-050599.
    1. Li Yan, Kong Nan, Lawley Mark, Weiss Linda, Pagán José A. Advancing the Use of Evidence-Based Decision-Making in Local Health Departments With Systems Science Methodologies. American Journal of Public Health. 2015;105(S2):S217–S222. doi: 10.2105/AJPH.2014.302077.
    1. Kruzikas DT, Higashi MK, Edgar M, Macal CM, North MJ, Graziano DJ, et al. Using agent-based modeling to inform regional health care system investment and planning. Proc - 2014 Int Conf Comput Sci Comput Intell CSCI. 2014;2:211–214. doi: 10.1109/CSCI.2014.120.
    1. Hirsch G, Homer J, Evans E, Zielinski A. A system dynamics model for planning cardiovascular disease interventions. Am J Public Health. 2010;100(4):616–622. doi: 10.2105/AJPH.2009.159434.
    1. Homer J, Milstein B, Wile K, Pratibhu P, Farris R, Orenstein DR. Modeling the local dynamics of cardiovascular health: risk factors, context, and capacity. Prev Chronic Dis. 2008;5(2):A63.
    1. Homer J. The prevention impacts simulation (PRISM) 2015.
    1. Kenealy T, Rees D, Sheridan N, Moffitt A, Tibby S, Homer J. A “whole of system” approach to compare options for CVD interventions in counties Manukau. Aust N Z J Public Health. 2012;36(3):263–268. doi: 10.1111/j.1753-6405.2011.00812.x.
    1. Homer J, Milstein B, Wile K, Trogdon J, Huang P, Labarthe D, et al. Simulating and evaluating local interventions to improve cardiovascular health. Prev Chronic Dis. 2010;7(1):A18. Available from: .
    1. Schmidt SM, Andrews T, Bibbins-Domingo K, Burt V, Cook NR, Ezzati M, et al. Proceedings from the workshop on estimating the contributions of sodium reduction to preventable death. CVD Prev Control. 2011;6(2):35–40. doi: 10.1016/j.cvdpc.2011.02.003.
    1. Loyo HK, Batcher C, Wile K, Huang P, Orenstein D, Milstein B. From model to action: using a system dynamics model of chronic disease risks to align community action. Health Promot Pract. 2013;14(1):53–61. doi: 10.1177/1524839910390305.
    1. Hirsch G, Homer J, Trogdon J, Wile K, Orenstein D. Using simulation to compare 4 categories of intervention for reducing cardiovascular disease risks. Am J Public Health. 2014;104(7):1187–1195. doi: 10.2105/AJPH.2013.301816.
    1. Homer J, Wile K, Yarnoff B, Trogdon JG, Hirsch G, Cooper L, et al. Using simulation to compare established and emerging interventions to reduce cardiovascular disease risk in the United States. Prev Chronic Dis. 2014;11:E195. Available from: .
    1. Forrester JW. Industrial dynamics. Cambridge, Massachusetts: Massachussetts Institute of Technology Press; 1961.
    1. Sterman JD. Business dynamics: systems thinking and modeling for a complex world: McGraw-Hill Higher Education; 2000.
    1. Abas ZA, Ramli MR, Desa MI, Saleh N, Hanafiah AN, Aziz N, et al. A supply model for nurse workforce projection in Malaysia. Health Care Manag Sci. 2017; Available from: . Accessed Feb 2019.
    1. Ghaffarzadegan N, Ebrahimvandi A, Jalali MS. A dynamic model of post-traumatic stress disorder for military personnel and veterans. PLoS One. 2016;11(10):1–17. doi: 10.1371/journal.pone.0161405.
    1. Ansah J, De Korne D, Bayer S, Pan C, Jayabaskar T, Matchar D, et al. Future requirements for and supply of ophthalmologists for an aging population in Singapore. Hum Resour Health. 2015;13(1):86. doi: 10.1186/s12960-015-0085-4.
    1. Sabounchi NS, Hovmand PS, Osgood ND, Dyck RF, Jungheim ES. A novel system dynamics model of female obesity and fertility. Am J Public Health. 2014;104(7):1240–1246. doi: 10.2105/AJPH.2014.301898.
    1. Adam TSN, Charlle S, Jie L. Proceedings of the 2011 Winter Simulation Conference, 11–14 Dec. 2011. A system dynamics model of Singapore healthcare affordability; pp. 2194–2205.
    1. Townshend J. R. P., Turner H. S. Analysing the Effectiveness of Chlamydia Screening. The Journal of the Operational Research Society. 2000;51(7):812. doi: 10.1057/palgrave.jors.2600978.
    1. Homer JB. A system dynamics model of national cocaine prevalence. Syst Dyn Rev. 1993;9(1):49–78. doi: 10.1002/sdr.4260090104.
    1. Lich KH, Tian Y, Beadles CA, Williams LS, Bravata DM, Cheng EM, et al. Strategic planning to reduce the burden of stroke among veterans: using simulation modeling to inform decision making. Stroke. 2014;45(7):2078–2084. doi: 10.1161/STROKEAHA.114.004694.
    1. SingStat. Population Trends 2017 [Internet]. 2018. Available from: . Accessed Jan 2019.
    1. SingStat. Monthly Household Income from Work Including Employer CPF Contributions. [Internet]. 2018. Available from: . Accessed Dec 2018.
    1. Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glucose to type 2 diabetes. Diabetes Care. 2007;30(2):228–233. doi: 10.2337/dc06-1392.
    1. Fonseca VA. Identification and treatment of prediabetes to prevent progression to type 2 diabetes. Clin Cornerstone. 2007;8(2):10–20. doi: 10.1016/S1098-3597(09)60004-1.
    1. Kim SJ, Lee J, Nam CM, Jee SH, Park IS, Lee KJ, et al. Progression rate from new-onset pre-hypertension to hypertension in Korean adults. Circ J. 2011;75(1):135–140. doi: 10.1253/circj.CJ-09-0948.
    1. Chobanian AV. Prehypertension revisited. Hypertension. 2006;48(5):812–814. doi: 10.1161/01.HYP.0000241684.29799.14.
    1. Neaton James D. Treatment of Mild Hypertension Study. JAMA. 1993;270(6):713. doi: 10.1001/jama.1993.03510060059034.
    1. NHIS. Adult Tobacco Use. Glossary [Internet]. National Health Interview Survey. 2015 [cited 2018 Jul 2]. Available from:
    1. Ministry of Health Singapore M. National Health Survey 2004 [Internet]. 2005. Available from: . Accessed Dec 2019.
    1. García-Rodríguez O, Secades-Villa R, Flórez-Salamanca L, Okuda M, Liu SM, Blanco C. Probability and predictors of relapse to smoking: results of the National Epidemiologic Survey on alcohol and related conditions (NESARC) Drug Alcohol Depend. 2013;132(3):479–485. doi: 10.1016/j.drugalcdep.2013.03.008.
    1. D’Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke. 1994;25(1):40–43. doi: 10.1161/01.STR.25.1.40.
    1. D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation. 2008;117(6):743–753. doi: 10.1161/CIRCULATIONAHA.107.699579.
    1. Ministry of Health Singapore M. Number of Deaths and Top 10 Principal Causes [Internet]. 2017. Available from: . Accessed Jan 2019.
    1. NRDO. Trends in stroke in singapore 2005–2013 [Internet]. 2015. Available from: . Accessed Jan 2019.
    1. Lackland DT, Carey RM, Conforto AB, Rosendorff C, Whelton PK, Gorelick PB. Implications of recent clinical trials and hypertension guidelines on stroke and future cerebrovascular research. Stroke. 2018;49(3):772–779. doi: 10.1161/STROKEAHA.117.019379.
    1. Patel A. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370(9590):829–840. doi: 10.1016/S0140-6736(07)61303-8.
    1. Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart. 2004;90(12):1398–1403. doi: 10.1136/hrt.2003.026104.
    1. Diabetes: The War Continues [Internet]. 2017 [cited 2018 Jul 23]. Available from:
    1. Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens. 2011;13(4):244–251. doi: 10.1111/j.1751-7176.2011.00434.x.
    1. Hurst Cameron, Thinkhamrop Bandit, Tran Hoang The. The Association between Hypertension Comorbidity and Microvascular Complications in Type 2 Diabetes Patients: A Nationwide Cross-Sectional Study in Thailand. Diabetes & Metabolism Journal. 2015;39(5):395. doi: 10.4093/dmj.2015.39.5.395.
    1. Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension: Final Results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265(24):3255–64. 10.1001/jama.1991.03460240051027.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する